信息Announcement Concerning Operational Suspension of Ofuna Plant due to Portfolio Transformation —Consolidation of manufacturing bases in Toyokalon business and withdrawal from Y Film and Caralyan business—

信息Announcement of Participation in the Taskforce on Nature-Related Financial Disclosures (TNFD) Forum

信息Announcement of Obtaining the Approval for the Use of Ebola Virus Antigen Rapid Diagnostic Kit “QuickNaviTM-Ebola” in the Democratic Republic of the Congo

IR信息FY2024 First Quarter Financial Results Presentation Summary of Q&A Session

IR信息FY2024 First Quarter Financial Results Presentation Materials

IR信息FY2024 First Quarter Summary of Consolidated Financial Statements

信息Decision of the U.S. Court of Appeals against an injunction filed by a U.S. subsidiary of Denka

信息Investment Made in a Startup to Launch the Carbon Nanotube (CNT) Business - Second Investment Project through the CVC Fund

IR信息Notice of Convocation of the 165th Ordinary General Meeting of Shareholders Other Matters Subject to the Electronic Provision

IR信息Notice of Convocation of the 165th Ordinary General Meeting of Shareholders

信息Announcement of the decision to invest in capital expenditure on the construction of a plant for the production of low-dielectric organic insulating material

IR信息FY2023 Financial Results Presentation Summary of Q&A Session

IR信息FY2023 Financial Results Presentation Materials

IR信息FY2023 Summary of Consolidated Financial Statements

信息Announcement of New Regulations set by the U.S. Environmental Protection Agency that apply to Chloroprene Rubber Manufacturing Facilities in the U.S.

信息Announcement of transfer of shares in acetylene gas affiliates to Koatsu Gas Kogyo Co., Ltd.

信息Temporary suspension lifted on ISO9001 certification of Denka equity-method affiliate

IR信息Announcement of Extraordinary Gains(Gain on Sale of Investment Securities)

IR信息FY2023 Third Quarter Financial Results Presentation Summary of Q&A Session

IR信息Announcement of Discontinuation of Development of a Norovirus Vaccine in an Overseas Consolidated Subsidiary and Recording of Extraordinary Loss

IR信息FY2023 Third Quarter Financial Results Presentation Materials

IR信息Notice Regarding Changes in Executive Officers

IR信息FY2023 Third Quarter Summary of Consolidated Financial Statements

信息Donations to Individuals and Areas Affected by the 2024 Noto Peninsula Earthquake

信息Impact of the 2024 Noto Peninsula Earthquake

信息Investment in Start-up for the Commercialization of Wearable Biosensor Measuring Health Data Using Sweat - The first investment via Denka’s new CVC fund -

信息新年贺词